Asthma Grand Rounds – Victoria, TX
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
This activity will cover the treatment and management of patients with AML.
This case-based live activity will cover the treatment and management of patients with hemophilia A
This program will review current and emerging therapies for the management of HER2-positive gastric cancer.
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).
This activity will cover the treatment and management of patients with type 2 diabetes mellitus (T2DM).
This program will review current and emerging therapies for the management of HER2-positive gastric cancer.
This activity will cover the treatment and management of patients with CLL.
This program will review current and emerging therapies for the management of HER2-positive gastric cancer.